凱龍高科(300912.SZ):子公司凱龍寶頓受新冠肺炎疫情影響 產品正常供應受阻
格隆匯7月30日丨凱龍高科(300912.SZ)公吿,自2021年7月20日南京市發現新一輪新型冠狀病毒肺炎確診病例以來,南京市多地調整為中高風險地區,公司控股子公司江蘇凱龍寶頓動力科技有限公司(簡稱“凱龍寶頓”)位於南京市江寧區祿口街道藍天路228號,處於疫情較為嚴重的地區。
據悉,凱龍寶頓響應了南京市新冠肺炎疫情聯防聯控工作指揮部部署,要求所有員工加強自我防護,全員核酸檢測,密切接觸人員居家隔離。
凱龍寶頓是凱龍高科控股子公司,主要生產柴油機國六後處理系統的核心部件:①尿素品質傳感器、②尿素液位傳感器、③尿素噴射管路。
自2021年7月21日起由於南京當地疫情防控要求,人員及生產物資均不能正常流動,凱龍寶頓生產產品無法正常供應無錫母公司,嚴重影響凱龍高科整體對外供貨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.